EU Post-Market Surveillance: How Doing More Than Minimum Will Benefit Medtech Manufacturers
Post-market surveillance requirements apply to all products under the EU’s Medical Device Regulation. Companies would do well to evaluate the additional benefits PMS can offer them, leading devices expert Bassil Akra explained during a recent interview.
You may also be interested in...
Only one new standard has been added to the official list of standards recognized in the context of the EU IVD Regulation in the latest update. The good news is that it is arguably one of the most needed standards by the IVD industry after the medtech quality management standard, ISO 13485.
The regulation of products on the drug/device borderline has always been complex. New EU guidance aims to provide clarification, but some difficult and nuanced decision-making is still left to the manufacturer.
Given the ongoing conflict in Ukraine, EU medtech notified bodies have been told to comply with sanctions intended to hurt companies based in Russia and Belarus.